Medplus Health Services Ltd.
ISIN: INE804L01022 • Market Cap: ₹7,807 Cr
The 5-Pillar Quality Audit for Medplus Health Services Ltd.
Evaluated across Profitability, Financial Health, Historical Compounding, Valuation Safety, and Ownership Governance:
1. Profitability & Capital Efficiency
Weight: 25%Measures operating margins (8.4%), Return on Capital Employed (12.9%), and equity compounding (11.1%).
2. Financial Health & Solvency
Weight: 25%Debt-to-Equity is 0.00 with comfortable interest coverage and clean working capital.
3. Growth & Compounding Track Record
Weight: 20%Historical 3Y Sales CAGR (8.7%) and 3Y PAT CAGR (47.6%).
4. Valuation Multiple & Margin of Safety
Weight: 15%Trades at P/E of 37.09 vs PEG of 2.32 and Dividend Yield of —.
5. Ownership Quality & Governance
Weight: 15%Promoter holding stands at 40.2%, backed by 44.3% institutional ownership.
Key Fundamental Strengths
Fortress Balance Sheet (D/E: 0.00)
The company operates virtually debt-free, shielding net margins from interest rate cycles and monetary tightening.
High-Velocity Profit Compounding (3Y PAT CAGR: 47.6%)
Net earnings have compounded at 47.6% annualized, demonstrating operating leverage.
Deep Institutional Sponsorship (44.3%)
Mutual funds, domestic DIIs, and foreign FIIs hold 44.3%, providing strong governance scrutiny.
Areas to Watch & Potential Risks
Sectoral & Macro Headwinds (Consumer Services)
Subject to broader cyclical demand, raw material price shifts, and regulatory frameworks governing the Consumer Services space.
Quantitative Strategy Eligibility
Checking MEDPLUS against established Indian wealth creation frameworks:
Coffee Can Investing Framework
Fails 10%+ revenue growth or 15%+ minimum capital return benchmark over historical periods.
Quality Factor Screener (High RoIC + Low Debt)
Qualifies for Indian Quality Indices with overall score of 70/100 and clean gearing.
GARP / Value-Growth Blend
Valuation multiple or return metrics require further cyclical pullback.
Consumer Services Sector Peer Comparison
Compare MEDPLUS directly against top industry peers by market capitalization:
| Company | 5-Pillar Score | Market Cap | P/E | ROCE | D/E | Scorecard |
|---|---|---|---|---|---|---|
| Medplus Health Services Ltd. (MEDPLUS)Current | 70/100 | ₹7,807 Cr | 37.09 | 12.9% | 0.00 | — |
| Eternal Ltd. (ETERNAL) | 61/100 | ₹3.09 Lakh Cr | 713.64 | 2.9% | 0.00 | View |
| Avenue Supermarts Ltd. (DMART) | 66/100 | ₹2.60 Lakh Cr | 84.88 | 16.4% | 0.04 | View |
| Trent Ltd. (TRENT) | 74/100 | ₹1.57 Lakh Cr | 86.78 | 29.6% | 0.07 | View |
| Lenskart Solutions Ltd. (LENSKART) | 63/100 | ₹1.11 Lakh Cr | 169.67 | 8.4% | 0.03 | View |
| Indian Hotels Co. Ltd. (INDHOTEL) | 75/100 | ₹1.03 Lakh Cr | 48.02 | 16.0% | 0.00 | View |
Frequently Asked Questions: Medplus Health Services Ltd.
Q:What is the 5-Pillar Fundamental Score for Medplus Health Services Ltd. (MEDPLUS)?
Medplus Health Services Ltd. has a RupeeTools Fundamental Score of 70/100, placing it in the 'Solid & Healthy' category. Its pillar scores are: Profitability (50/100), Financial Health (83/100), Growth (78/100), Valuation (62/100), and Ownership Quality (78/100).
Q:Is MEDPLUS fundamentally strong for long-term investment?
Yes, MEDPLUS exhibits solid fundamental strength with a 70/100 score, driven by a return on equity of 11.1% and a debt-to-equity ratio of 0.00.
Q:Does MEDPLUS pass the Coffee Can Investing filter?
No. MEDPLUS does not currently meet the strict 15% ROCE and 10% sustained topline compounding threshold mandated by the Coffee Can investing framework.
Q:How does MEDPLUS compare against other Consumer Services peers?
Within India's Consumer Services sector, MEDPLUS trades at a P/E of 37.09 and generates an ROCE of 12.9%. Compare its 5-Pillar score of 70/100 against top sector peers like Eternal Ltd. (61/100), Avenue Supermarts Ltd. (66/100).
Regulatory & SEBI Research Analyst Compliance Disclaimer:
This 5-pillar fundamental score is an automated quantitative health check generated purely from historical public financial statements, corporate filings, and exchange disclosures for educational and informational purposes only. It does NOT constitute investment advice, a stock recommendation, or a solicitation to buy or sell securities. RupeeTools is not a SEBI-registered Research Analyst. Please consult a SEBI-registered financial advisor before making investment decisions.